Evidence-based clinical practice guidelines for inflammatory bowel disease
2018 · Journal of Gastroenterology · 684 citations
https://doi.org/10.1007/s00535-018-1439-1
R
Reiko Kunisaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
168
Papers
3.1K
Citations
27
h-index
49
i10-index
Reiko Kunisaki is an academic researcher from Yokohama City University Medical Center. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Autoimmune and Inflammatory Disorders. The author has an h-index of 27, co-authored 143 publications.
ORCID: 0000-0003-3083-9600Papers by this author
worksEvidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
2020 · Journal of Gastroenterology · 69 citations
https://doi.org/10.1007/s00535-020-01690-y
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
2022 · Journal of Gastroenterology · 10 citations
https://doi.org/10.1007/s00535-022-01851-1
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study
2024 · Journal of Gastroenterology · 9 citations
https://doi.org/10.1007/s00535-024-02176-x
Utility of a rapid assay for prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis
2023 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-023-37145-6
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
2025 · Journal of Gastroenterology · 6 citations
https://doi.org/10.1007/s00535-025-02216-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat